Targeting the hypoxia inducible factor pathway with mitochondrial uncouplers

Area of Science:

• Oncology
• Cellular Biology
• Biochemistry

Background:

• Hypoxia-inducible factor-1 (HIF-1) regulates tumor adaptation to hypoxia.
• HIF-1 comprises HIF-1alpha/2alpha and HIF-1beta subunits.
• Mitochondrial uncouplers like rottlerin and FCCP increase cellular oxygen consumption.

Purpose of the Study:

• To investigate the effect of mitochondrial uncouplers on HIF-1 transcriptional activity.
• To determine the impact of these uncouplers on HIF-1alpha and HIF-2alpha protein levels.
• To assess the influence on HIF target genes in prostate cancer cells.

Main Methods:

• Treatment of PC-3 and DU-145 prostate cancer cells with rottlerin and FCCP.
• Measurement of HIF-1 transcriptional activity under normoxic and hypoxic conditions.
• Analysis of HIF-1alpha, HIF-2alpha, VEGF, and VEGF receptor-2 expression.

Main Results:

• Mitochondrial uncouplers significantly decreased HIF-1 transcriptional activity in both normoxia and hypoxia.
• Rottlerin and FCCP reduced the protein levels of oxygen-sensitive HIF-1alpha and HIF-2alpha.
• Expression of HIF target genes VEGF and VEGF receptor-2 was decreased by mitochondrial uncouplers.

Conclusions:

• Functional mitochondria are crucial for the stability and activity of HIF-1alpha and HIF-2alpha.
• Mitochondrial uncouplers inhibit the HIF pathway in prostate cancer cells.
• Mitochondrial uncouplers show potential as therapeutic agents for inhibiting HIF signaling in tumors.